Economic evaluation of cemiplimab plus chemotherapy regimen for advanced non-small-cell lung cancer. Lang Y, Lin Y, Deng M, Liu X, et al. BMC Cancer 2024;24:236.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lang Y, Lin Y, Deng M, Liu X, et al. Economic evaluation of cemiplimab plus chemotherapy regimen for advanced non-small-cell lung cancer. BMC Cancer 2024;24:236.
PMID: 38383374